Co-Diagnostics, Inc. (CODX) Q2 2024 Earnings
CODX·Reported August 8, 2024·After market close
Co-Diagnostics, Inc. reported Q2 2024 revenue of $2.7M, beat analyst consensus of $370.0K by $2.3M. Diluted EPS came in at $-0.25, beat the $-0.34 consensus by $0.09.
Revenue
$2.7Mbeat by $2.3M
Consensus: $370.0KDiluted EPS
$-0.25beat by $0.09
Consensus: $-0.34
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Co-Diagnostics, Inc. 's Q2 2024 earnings report.
Co-Diagnostics, Inc. (CODX) reported Q2 2024 earnings on August 8, 2024 after market close.
Co-Diagnostics, Inc. reported revenue of $2.7M and diluted EPS of $-0.25 for Q2 2024.
Revenue beat the consensus estimate of $370.0K by $2.3M. EPS beat the consensus estimate of $-0.34 by $0.09.
You can read the 10-Q periodic report (0001493152-24-030758) directly on SEC EDGAR. The filing index links above go to sec.gov.